EGFR and K-ras mutations as determinants of gefitinib sensitivity in non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Han, SW
Jeong, S
Choi, IS
Kim, DN
Chung, DH
Im, SA
Kim, TY
Heo, DS
Bang, YJ
Kim, NK
机构：
[1] Seoul Natl Univ, Coll Med, Seoul, South Korea
[2] ISU ABXIS Inc, Seoul, South Korea
[3] Seoul Municipal Boramae Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：639S / 639S
页数：1
相关论文
共 50 条
  • [21] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [22] Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients
    Ramirez, JL
    Sarries, C
    de Castro, PL
    Roig, B
    Queralt, C
    Escuin, D
    de Aguirre, I
    Sanchez, JM
    Manzano, JL
    Margelí, M
    Sanchez, JJ
    Astudillo, J
    Taron, M
    Rosell, R
    CANCER LETTERS, 2003, 193 (02) : 207 - 216
  • [23] EGFR AND K-RAS ANALYSIS IN CYTOLOGICAL SPECIMENS FROM NON SMALL CELL LUNG CANCER
    Puccetti, Maurizio
    Ulivi, Paola
    Chiadini, Elisa
    Capelli, Laura
    Candoli, Piero
    Zoli, Wainer
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S970 - S970
  • [24] Advanced non-small-cell Lung Cancer (NSCLC) Solid Options for EGFR-Mutations
    Roos, Martin
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (10) : 639 - 639
  • [25] FREQUENCY OF EGFR MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) FROM GREEK PATIENTS
    Papadopoulou, E.
    Murray, S.
    Efstathiadou, C.
    Nasioulas, G.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S35 - S36
  • [26] Activity of Gefitinib in a Non-Small-Cell Lung Cancer Patient with Both Activating and Resistance EGFR Mutations
    Morabito, Alessandro
    Costanzo, Raffaele
    Rachiglio, Anna Maria
    Pasquale, Raffaella
    Sandomenico, Claudia
    Franco, Renato
    Montanino, Agnese
    De Lutio, Elisabetta
    Rocco, Gaetano
    Normanno, Nicola
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : E59 - E60
  • [27] EGFR mutations in non-small-cell lung cancer reply
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    LANCET ONCOLOGY, 2010, 11 (05): : 413 - 413
  • [28] Analysis of the prognostic role of plasmatic K-ras mutations in advanced non-small cell lung cancer (NSCLC) patients
    Sirera, R.
    Camps, C.
    Berrocal, A.
    Munoz-Navarro, M.
    Garcia-Gomez, R.
    Vinolas, N.
    Artal, A.
    Guillot, M.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] COST-EFFECTIVENESS ANALYSIS OF EGFR TESTING AND GEFITINIB FOR NON-SMALL-CELL LUNG CANCER (NSCLC) IN JAPAN
    Shiroiwa, T.
    Miyoshi, Y.
    Tsutani, K.
    VALUE IN HEALTH, 2012, 15 (04) : A67 - A67
  • [30] Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
    Tiseo, M.
    Bartolotti, M.
    Gelsomino, F.
    Bordi, P.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 81 - 98
12345